BTIG analyst Justin Zelin raised the price target on Viking Therapeutic (NASDAQ: VKTX) to $125.00 (from $100.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments Analyst PT Change

Viking Therapeutic (VKTX) PT Raised to $95 at StifelMarch 26, 2024 10:57 AM Midday movers: Krispy Kreme, Tesla, and Reddit riseMarch 26, 2024 8:14 AM Viking Therapeutics' weight-loss tablet shows promise in small studyMarch 26, 2024 7:12 AM Viking (VKTX) Climbs 10% Following Results from Phase 1 Trial of Dual GLP-1/GIP Receptor Agonist VK2735March 26, 2024 7:09 AM Form 8-K Viking Therapeutics, For: Mar 26March 26, 2024 7:08 AM Viking Therapeutics (VKTX) Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of VK2735March 26, 2024 7:03 AM Viking Therapeutics Announces Results from Phase 1 Clinical Trial of Oral Tablet Formulation of Dual GLP-1/GIP Receptor Agonist VK2735March 26, 2024 7:03 AM